Integra LifeSciences Holdings Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Integra LifeSciences Holdings de 36.8% y 5.5% por año respectivamente. Se prevé que el BPA crezca en un 34.6% al año. Se espera que la rentabilidad financiera sea de 20.9% en 3 años.
Información clave
36.8%
Tasa de crecimiento de los beneficios
34.6%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 16.2% |
| Tasa de crecimiento de los ingresos | 5.5% |
| Rentabilidad financiera futura | 20.9% |
| Cobertura de analistas | Good |
| Última actualización | 25 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?
Oct 19We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Oct 05Integra LifeSciences: Wide Dislocation In Fundamentals Vs. Market Value
Sep 13Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 06FDA labels recall of intracranial pressure monitors by Integra as most serious
Aug 31Integra Lifesciences voluntarily recalls pressure monitors, lowers revenue, profit guidance
Aug 24Returns At Integra LifeSciences Holdings (NASDAQ:IART) Appear To Be Weighed Down
Aug 23Integra LifeSciences founder/former CEO dies
Aug 16Integra LifeSciences Holdings GAAP EPS of $0.54 beats by $0.09, revenue of $398M beats by $2.62M
Jul 27Is There An Opportunity With Integra LifeSciences Holdings Corporation's (NASDAQ:IART) 47% Undervaluation?
Jul 20These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Jul 07Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 1,826 | 231 | 283 | 338 | 5 |
| 12/31/2025 | 1,711 | 174 | 238 | 295 | 12 |
| 12/31/2024 | 1,616 | 117 | 190 | 220 | 12 |
| 12/31/2023 | 1,542 | 68 | 73 | 140 | N/A |
| 9/30/2023 | 1,543 | 101 | 110 | 167 | N/A |
| 6/30/2023 | 1,545 | 131 | 155 | 208 | N/A |
| 3/31/2023 | 1,562 | 172 | 200 | 246 | N/A |
| 12/31/2022 | 1,558 | 181 | 217 | 264 | N/A |
| 9/30/2022 | 1,565 | 173 | 188 | 248 | N/A |
| 6/30/2022 | 1,567 | 166 | 205 | 263 | N/A |
| 3/31/2022 | 1,559 | 157 | 232 | 288 | N/A |
| 12/31/2021 | 1,542 | 169 | 264 | 312 | N/A |
| 9/30/2021 | 1,526 | 216 | 274 | 323 | N/A |
| 6/30/2021 | 1,509 | 206 | 262 | 310 | N/A |
| 3/31/2021 | 1,378 | 170 | 203 | 252 | N/A |
| 12/31/2020 | 1,372 | 134 | 140 | 204 | N/A |
| 9/30/2020 | 1,378 | 56 | 155 | 213 | N/A |
| 6/30/2020 | 1,387 | -3 | 78 | 207 | N/A |
| 3/31/2020 | 1,512 | 27 | 83 | 223 | N/A |
| 12/31/2019 | 1,518 | 50 | 97 | 231 | N/A |
| 9/30/2019 | 1,506 | 60 | 47 | 185 | N/A |
| 6/30/2019 | 1,493 | 101 | 124 | 200 | N/A |
| 3/31/2019 | 1,475 | 83 | 109 | 188 | N/A |
| 12/31/2018 | 1,472 | 61 | 122 | 200 | N/A |
| 9/30/2018 | 1,458 | 80 | 103 | 169 | N/A |
| 6/30/2018 | 1,371 | 70 | 78 | 135 | N/A |
| 3/31/2018 | 1,287 | 69 | 77 | 127 | N/A |
| 12/31/2017 | 1,188 | 65 | 71 | 115 | N/A |
| 9/30/2017 | 1,075 | 49 | N/A | 110 | N/A |
| 6/30/2017 | 1,047 | 66 | N/A | 111 | N/A |
| 3/31/2017 | 1,014 | 68 | N/A | 120 | N/A |
| 12/31/2016 | 992 | 75 | N/A | 116 | N/A |
| 9/30/2016 | 985 | 61 | N/A | 136 | N/A |
| 6/30/2016 | 958 | 9 | N/A | 108 | N/A |
| 3/31/2016 | 919 | 9 | N/A | 98 | N/A |
| 12/31/2015 | 883 | 7 | N/A | 105 | N/A |
| 9/30/2015 | 854 | 12 | N/A | 100 | N/A |
| 6/30/2015 | 827 | 53 | N/A | 111 | N/A |
| 3/31/2015 | 782 | 46 | N/A | 100 | N/A |
| 12/31/2014 | 797 | 36 | N/A | 84 | N/A |
| 9/30/2014 | 798 | 30 | N/A | 70 | N/A |
| 6/30/2014 | 814 | -10 | N/A | 70 | N/A |
| 3/31/2014 | 855 | -13 | N/A | 57 | N/A |
| 12/31/2013 | 697 | 22 | N/A | 53 | N/A |
| 9/30/2013 | 830 | -22 | N/A | 38 | N/A |
| 6/30/2013 | 827 | 21 | N/A | 35 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (36.8% al año) de IART es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (36.8% al año) de IART crezcan más rápidamente que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de IART crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (5.5% al año) de IART crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 5.5% al año) de IART crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de IART sea alta dentro de 3 años (20.9%)